Verizon To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Tuesday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Tuesday, with changes in price targets and ratings for multiple companies. Notable changes include Stifel's downgrade of Hersha Hospitality Trust (HT) from Buy to Hold, Citigroup's upgrade of Verizon Communications (VZ) from Neutral to Buy, and UBS's upgrade of Oracle Corporation (ORCL) from Neutral to Buy. Other companies mentioned include Forward Air Corporation (FWRD), Celanese Corporation (CE), Rockwell Automation (ROK), Farfetch Limited (FTCH), ImmunoGen (IMGN), BeiGene (BGNE), and Kymera Therapeutics (KYMR).
August 29, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler downgraded Celanese Corporation from Neutral to Underweight and slashed the price target from $120 to $112.
The downgrade from Neutral to Underweight suggests that the analyst believes the stock will underperform the market in the near future, which could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Morgan Stanley downgraded Farfetch Limited from Overweight to Equal-Weight and cut the price target from $20 to $5.
The downgrade from Overweight to Equal-Weight suggests that the analyst believes the stock will perform in line with the market in the near future, which could negatively impact the stock price, especially given the significant cut in price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Stifel downgraded Hersha Hospitality Trust from Buy to Hold and raised the price target from $8.75 to $10.
The downgrade from Buy to Hold suggests that the analyst believes the stock may not outperform the market in the near future, which could negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Morgan Stanley maintained an Equal-Weight rating for Kymera Therapeutics and cut the price target from $39 to $37.
The maintained Equal-Weight rating suggests that the analyst believes the stock will perform in line with the market in the near future, which could have a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Wells Fargo upgraded Rockwell Automation from Underweight to Equal-Weight and boosted the price target from $290 to $317.
The upgrade from Underweight to Equal-Weight suggests that the analyst believes the stock will perform in line with the market in the near future, which could have a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Morgan Stanley maintained an Overweight rating for BeiGene and lowered the price target from $321 to $319.
The maintained Overweight rating suggests that the analyst continues to believe the stock will outperform the market in the near future, which could positively impact the stock price, despite the slight cut in price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jefferies upgraded Forward Air Corporation from Hold to Buy and cut the price target from $110 to $85.
The upgrade from Hold to Buy suggests that the analyst believes the stock will outperform the market in the near future, which could positively impact the stock price, despite the cut in price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co. maintained a Buy rating for ImmunoGen and boosted the price target from $26 to $27.
The maintained Buy rating suggests that the analyst continues to believe the stock will outperform the market in the near future, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
UBS upgraded Oracle Corporation from Neutral to Buy and boosted the price target from $120 to $140.
The upgrade from Neutral to Buy suggests that the analyst believes the stock will outperform the market in the near future, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Citigroup upgraded Verizon Communications from Neutral to Buy and increased the price target from $39 to $40.
The upgrade from Neutral to Buy suggests that the analyst believes the stock will outperform the market in the near future, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100